These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26988305)

  • 1. Inhibitors of HIV-1 maturation: Development of structure-activity relationship for C-28 amides based on C-3 benzoic acid-modified triterpenoids.
    Swidorski JJ; Liu Z; Sit SY; Chen J; Chen Y; Sin N; Venables BL; Parker DD; Nowicka-Sans B; Terry BJ; Protack T; Rahematpura S; Hanumegowda U; Jenkins S; Krystal M; Dicker IB; Meanwell NA; Regueiro-Ren A
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1925-30. PubMed ID: 26988305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors.
    Liu Z; Swidorski JJ; Nowicka-Sans B; Terry B; Protack T; Lin Z; Samanta H; Zhang S; Li Z; Parker DD; Rahematpura S; Jenkins S; Beno BR; Krystal M; Meanwell NA; Dicker IB; Regueiro-Ren A
    Bioorg Med Chem; 2016 Apr; 24(8):1757-70. PubMed ID: 26968652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and exploration of C-3 benzoic acid bioisosteres and alkyl replacements in the context of GSK3532795 (BMS-955176) that exhibit broad spectrum HIV-1 maturation inhibition.
    Swidorski JJ; Jenkins S; Hanumegowda U; Parker DD; Beno BR; Protack T; Ng A; Gupta A; Shanmugam Y; Dicker IB; Krystal M; Meanwell NA; Regueiro-Ren A
    Bioorg Med Chem Lett; 2021 Mar; 36():127823. PubMed ID: 33508465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176).
    Regueiro-Ren A; Swidorski JJ; Liu Z; Chen Y; Sin N; Sit SY; Chen J; Venables BL; Zhu J; Nowicka-Sans B; Protack T; Lin Z; Terry B; Samanta H; Zhang S; Li Z; Easter J; Beno BR; Arora V; Huang XS; Rahematpura S; Parker DD; Haskell R; Santone KS; Cockett MI; Krystal M; Meanwell NA; Jenkins S; Hanumegowda U; Dicker IB
    J Med Chem; 2018 Aug; 61(16):7289-7313. PubMed ID: 30067361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms.
    Tang J; Jones SA; Jeffrey JL; Miranda SR; Galardi CM; Irlbeck DM; Brown KW; McDanal CB; Johns BA
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2689-2694. PubMed ID: 28454672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation.
    Chen Y; Sit SY; Chen J; Swidorski JJ; Liu Z; Sin N; Venables BL; Parker DD; Nowicka-Sans B; Lin Z; Li Z; Terry BJ; Protack T; Rahematpura S; Hanumegowda U; Jenkins S; Krystal M; Dicker ID; Meanwell NA; Regueiro-Ren A
    Bioorg Med Chem Lett; 2018 May; 28(9):1550-1557. PubMed ID: 29631960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity.
    Li J; Goto M; Yang X; Morris-Natschke SL; Huang L; Chen CH; Lee KH
    Bioorg Med Chem Lett; 2016 Jan; 26(1):68-71. PubMed ID: 26598461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants.
    Dang Z; Qian K; Ho P; Zhu L; Lee KH; Huang L; Chen CH
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5190-4. PubMed ID: 22818973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation.
    Regueiro-Ren A; Sit SY; Chen Y; Chen J; Swidorski JJ; Liu Z; Venables BL; Sin N; Hartz RA; Protack T; Lin Z; Zhang S; Li Z; Wu DR; Li P; Kempson J; Hou X; Gupta A; Rampulla R; Mathur A; Park H; Sarjeant A; Benitex Y; Rahematpura S; Parker D; Phillips T; Haskell R; Jenkins S; Santone KS; Cockett M; Hanumegowda U; Dicker I; Meanwell NA; Krystal M
    J Med Chem; 2022 Sep; 65(18):11927-11948. PubMed ID: 36044257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice.
    Stoddart CA; Joshi P; Sloan B; Bare JC; Smith PC; Allaway GP; Wild CT; Martin DE
    PLoS One; 2007 Nov; 2(11):e1251. PubMed ID: 18043758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors.
    Qian K; Kuo RY; Chen CH; Huang L; Morris-Natschke SL; Lee KH
    J Med Chem; 2010 Apr; 53(8):3133-41. PubMed ID: 20329730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site.
    Coric P; Turcaud S; Souquet F; Briant L; Gay B; Royer J; Chazal N; Bouaziz S
    Eur J Med Chem; 2013 Apr; 62():453-65. PubMed ID: 23399723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors.
    Qian K; Bori ID; Chen CH; Huang L; Lee KH
    J Med Chem; 2012 Sep; 55(18):8128-36. PubMed ID: 22978745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and synthesis of novel beesioside I derivatives with potent anti-HIV activity.
    Wu H; Ma G; Yang Q; Zhu Y; Huang L; Tian Y; Yang X; Zhang M; Chen CH; Morris-Natschke SL; Yang M; Xu X; Lee KH
    Eur J Med Chem; 2019 Mar; 166():159-166. PubMed ID: 30703659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid.
    Sun IC; Chen CH; Kashiwada Y; Wu JH; Wang HK; Lee KH
    J Med Chem; 2002 Sep; 45(19):4271-5. PubMed ID: 12213068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpene based compounds with potent anti-maturation activity against HIV-1.
    Gerrish D; Kim IC; Kumar DV; Austin H; Garrus JE; Baichwal V; Saunders M; McKinnon RS; Anderson MB; Carlson R; Arranz-Plaza E; Yager KM
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6377-80. PubMed ID: 18996008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design and discovery of novel amide CCR5 antagonists.
    Pryde DC; Corless M; Fenwick DR; Mason HJ; Stammen BC; Stephenson PT; Ellis D; Bachelor D; Gordon D; Barber CG; Wood A; Middleton DS; Blakemore DC; Parsons GC; Eastwood R; Platts MY; Statham K; Paradowski KA; Burt C; Klute W
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1084-8. PubMed ID: 19167884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents.
    Qian K; Yu D; Chen CH; Huang L; Morris-Natschke SL; Nitz TJ; Salzwedel K; Reddick M; Allaway GP; Lee KH
    J Med Chem; 2009 May; 52(10):3248-58. PubMed ID: 19388685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation inhibitors: a new therapeutic class targets the virus structure.
    Salzwedel K; Martin DE; Sakalian M
    AIDS Rev; 2007; 9(3):162-72. PubMed ID: 17982941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected Plant Triterpenoids and Their Derivatives as Antiviral Agents.
    Wimmerová M; Bildziukevich U; Wimmer Z
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.